At a Glance
Dosage
insufflated
| Level | A-PVP | 2-FMA |
|---|---|---|
| Threshold | 0.5 mg | 5 mg |
| Light | 1–5 mg | 5–15 mg |
| Common | 5–15 mg | 15–30 mg |
| Strong | 15–25 mg | 30–50 mg |
| Heavy | 25 mg | 50 mg |
oral
| Level | A-PVP | 2-FMA |
|---|---|---|
| Threshold | 1 mg | 5 mg |
Duration
insufflated
A-PVP
insufflated
Total: 2 hrs – 5 hrsOffset
Afterglow
Onset10 min – 30 min
Peak20 min – 45 min
Offset30 min – 1.5 hrs
Afterglow2 hrs – 4 hrs
2-FMA
Effects
Safety
Interaction: A-PVP + 2-FMA
No direct interaction data available between these substances. This does not mean the combination is safe.
A-PVP — Dangerous Interactions
2-FMA — Dangerous Interactions
Frequently Asked Questions
What is the difference between A-PVP and 2-FMA?
A-PVP is classified as a Stimulants (Cathinone, Substituted cathinones, Substituted pyrrolidines) while 2-FMA is classified as a Stimulants (Amphetamine, Substituted amphetamines). They share 35 effects in common, with 13 effects unique to A-PVP and 16 unique to 2-FMA.
Is it safe to combine A-PVP and 2-FMA?
There is no direct interaction data available for combining A-PVP and 2-FMA. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, A-PVP or 2-FMA?
At common doses via insufflated, A-PVP is typically dosed at 5–15 mg while 2-FMA is dosed at 15–30 mg. However, "stronger" depends on context — potency, subjective intensity, and duration all factor in. These substances have different pharmacological profiles and comparing raw potency is not straightforward.